Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

2 results about "Active center" patented technology

An active center (sometimes called active site or kinetic-chain carrier) in polymer science refers to the site on a chain carrier at which reaction occurs.

Modified PVC (Polyvinyl Chloride) composite material and preparation method thereof

InactiveCN107474428AImprove creep resistanceImprove low temperature impact performancePlastic/resin/waxes insulatorsActive agentPolyvinyl chloride
The invention discloses a PVC (Polyvinyl Chloride) composite modified material and a preparation method thereof, relates to a PVC modified material and a preparation method thereof, and aims to solve the problems that a product surface is rough and lusterless as a conventional PVC modified material has a certain amount of unsaturated double bonds on a molecular chain, an active center can be formed and thus the ductility is low and a melt is easily crushed. The PVC composite modified material is prepared from the following components in parts by weight: a PVC resin, a low-temperature flexibilizer, an impact modifier, processing aids, a surfactant, a composite stabilizer, a covering agent, an initiator and a cross-linking agent. The preparation method comprises the following steps: I, weighing; II, premixing so as to obtain a premix; III, mixing at different steps so as to obtain mixtures of different steps; IV, performing final mixing so as to obtain a final mixture; and V, performing extrusion pelletizing, thereby obtaining the PVC composite modified material. The invention aims to prepare the PVC composite modified material.
Owner:WUHU PILOT NEW MATERIAL TECH CO LTD

Inhibitors of mTORC2

PendingCN114702552AInhibition of activationInhibit phosphorylationNervous disorderPeptide/protein ingredientsPhosphorylationKinase
The invention discloses an mTORC2 (mammalian TORC2) inhibitor. According to the application, an mTORC2 inhibitor is designed and developed on the basis of a protein region Sin1-N structure of an mTORC2 specific subunit Sin1, and the mTORC2 inhibitor specifically inhibits activation of mTORC2 and specifically inhibits phosphorylation of a downstream kinase Akt activation site Ser473; compared with the existing mTOR inhibition active center-oriented small-molecule inhibitor, the variable configuration inhibitor has the advantages of strong inhibition effect and small side effect.
Owner:SUZHOU SITRI INST OF IMMUNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products